A 55-year-old woman with end-stage renal failure on peritoneal dialysis presents with a 3-day history of fever, headache, and confusion. She has a history of recurrent peritonitis episodes. Lumbar puncture shows: glucose 2.5 mmol/L (serum 5.8 mmol/L), protein 1.5 g/L, white cells 580/mm³ (85% neutrophils). Gram stain shows Gram-positive cocci in clusters. Blood cultures grow methicillin-resistant Staphylococcus aureus (MRSA). She has normal hearing and no documented aminoglycoside allergy. What is the most appropriate antimicrobial regimen for this patient?
Q162
A 39-year-old homeless man with alcohol dependency presents with a 5-week history of productive cough, haemoptysis, weight loss, and drenching night sweats. Chest X-ray shows bilateral upper lobe cavitation with a large cavity (4 cm) in the right upper lobe. Three sputum samples are smear-positive (3+ acid-fast bacilli). He is started on rifampicin, isoniazid, pyrazinamide, and ethambutol. Culture at 6 weeks grows Mycobacterium tuberculosis fully sensitive to all first-line drugs. After 2 months of treatment, he remains sputum smear-positive. What is the most appropriate modification to his treatment regimen?
Q163
A 22-year-old university student presents to the emergency department with an 18-hour history of severe headache, photophobia, vomiting, and neck stiffness. Temperature is 39.2°C. There are no skin lesions. Lumbar puncture shows: opening pressure 32 cmH2O, glucose 1.9 mmol/L (serum 5.4 mmol/L), protein 2.4 g/L, white cells 2400/mm³ (95% neutrophils). Gram stain is negative. He is started on ceftriaxone and aciclovir. Blood and CSF cultures remain negative at 48 hours, and HSV PCR is negative. What is the most likely explanation for the negative microbiological results?
Q164
A 46-year-old man with smear-positive pulmonary tuberculosis has been receiving standard four-drug therapy for 8 weeks. His initial isolate showed susceptibility to all first-line drugs. He reports good adherence to treatment. Repeat sputum microscopy at 8 weeks remains smear-positive (2+ acid-fast bacilli). Repeat culture from week 6 shows growth of Mycobacterium tuberculosis. What is the most appropriate interpretation and management at this stage?
Q165
A 63-year-old woman presents with confusion, fever, and right-sided focal seizures. She has a background of type 2 diabetes and chronic sinusitis. CT head shows a right temporal lobe lesion with surrounding oedema. Lumbar puncture shows: opening pressure 22 cmH2O, glucose 3.2 mmol/L (serum 7.8 mmol/L), protein 1.2 g/L, white cells 425/mm³ (65% neutrophils, 35% lymphocytes), red cells 85/mm³. Gram stain shows Gram-positive cocci in chains. What is the most appropriate initial antimicrobial regimen?
Q166
A 35-year-old man from Afghanistan presents with a 10-week history of fever, night sweats, and back pain. MRI spine shows destruction of T10-T11 vertebrae with paraspinal abscess formation and spinal cord compression. He is neurologically intact. Three sputum samples are negative for acid-fast bacilli. What is the most appropriate immediate management approach?
Q167
A 4-year-old boy presents with a 12-hour history of fever, irritability, and drowsiness. On examination, he has a capillary refill time of 4 seconds, heart rate 155/min, blood pressure 85/50 mmHg, and a spreading non-blanching purpuric rash on his legs and trunk. He is managed in the emergency department with immediate antibiotics. His 18-month-old sibling attends the same nursery and has no symptoms. What is the most appropriate prophylaxis for the sibling?
Q168
A 28-year-old healthcare worker sustains a needlestick injury from a patient with confirmed multidrug-resistant tuberculosis (resistant to rifampicin and isoniazid). The healthcare worker has no symptoms and chest X-ray is normal. Mantoux test performed 48 hours ago shows 8 mm induration. She has no documented BCG vaccination. What is the most appropriate management for this exposed healthcare worker?
Q169
A 43-year-old man with HIV infection (CD4 count 95 cells/mm³, not on antiretroviral therapy) presents with a 3-week history of headache and fever. CT head shows multiple ring-enhancing lesions. Lumbar puncture shows: opening pressure 19 cmH2O, glucose 2.8 mmol/L (serum 5.2 mmol/L), protein 0.65 g/L, white cells 12/mm³ (lymphocytes). India ink stain is positive. Serum cryptococcal antigen titre is 1:2048. What is the most appropriate initial management strategy?
Q170
A 31-year-old woman from Pakistan presents with a 6-week history of progressive headache, low-grade fever, and confusion. She is currently 20 weeks pregnant. MRI brain shows basal meningeal enhancement and hydrocephalus. CSF analysis shows: glucose 1.8 mmol/L (serum 4.5 mmol/L), protein 2.5 g/L, white cells 180/mm³ (80% lymphocytes). ZN stain is pending. Which combination represents the most appropriate initial treatment regimen for this patient?
Serious & Notifiable Infections UK Medical PG Practice Questions and MCQs
Question 161: A 55-year-old woman with end-stage renal failure on peritoneal dialysis presents with a 3-day history of fever, headache, and confusion. She has a history of recurrent peritonitis episodes. Lumbar puncture shows: glucose 2.5 mmol/L (serum 5.8 mmol/L), protein 1.5 g/L, white cells 580/mm³ (85% neutrophils). Gram stain shows Gram-positive cocci in clusters. Blood cultures grow methicillin-resistant Staphylococcus aureus (MRSA). She has normal hearing and no documented aminoglycoside allergy. What is the most appropriate antimicrobial regimen for this patient?
A. Intravenous vancomycin with dose adjustment for renal function and therapeutic drug monitoring
B. Intravenous linezolid 600 mg twice daily for 14 days (Correct Answer)
C. Intravenous teicoplanin with loading doses then maintenance dosing guided by levels
D. Intravenous daptomycin 10 mg/kg once daily
E. Intravenous vancomycin plus rifampicin for synergy
Explanation: ***Intravenous linezolid 600 mg twice daily for 14 days***- **Linezolid** is the preferred agent for **MRSA meningitis** due to its excellent **CSF penetration** (approximately 70%), which is crucial for treating CNS infections.- It does not require **dose adjustment** for **renal impairment**, making it an ideal choice for patients with **end-stage renal failure**.*Intravenous vancomycin with dose adjustment for renal function and therapeutic drug monitoring*- **Vancomycin** has notoriously poor **CSF penetration** (10-20%), making it difficult to achieve adequate bactericidal concentrations in the meninges.- In patients with **renal failure**, **vancomycin** requires careful **dose adjustment** and **therapeutic drug monitoring (TDM)** to prevent **nephrotoxicity** and **ototoxicity**, adding complexity.*Intravenous teicoplanin with loading doses then maintenance dosing guided by levels*- **Teicoplanin**, similar to vancomycin, is a large glycopeptide with very poor **central nervous system penetration**, rendering it ineffective for treating **bacterial meningitis**.- It is generally not recommended for CNS infections due to its inability to achieve sufficient bactericidal concentrations in the **cerebrospinal fluid (CSF)**.*Intravenous daptomycin 10 mg/kg once daily*- **Daptomycin** does not effectively penetrate the **blood-brain barrier** and is therefore contraindicated for the treatment of **meningitis**.- Its high protein binding and large molecular size prevent it from reaching therapeutic levels in the **cerebrospinal fluid (CSF)**.*Intravenous vancomycin plus rifampicin for synergy*- While **rifampicin** has good **CNS penetration**, the primary anti-MRSA agent, **vancomycin**, still suffers from poor **CSF bioavailability**.- Adding **rifampicin** might be considered for synergistic effect in some MRSA infections, but **linezolid monotherapy** is superior for **MRSA meningitis** due to its inherent excellent CSF penetration.
Question 162: A 39-year-old homeless man with alcohol dependency presents with a 5-week history of productive cough, haemoptysis, weight loss, and drenching night sweats. Chest X-ray shows bilateral upper lobe cavitation with a large cavity (4 cm) in the right upper lobe. Three sputum samples are smear-positive (3+ acid-fast bacilli). He is started on rifampicin, isoniazid, pyrazinamide, and ethambutol. Culture at 6 weeks grows Mycobacterium tuberculosis fully sensitive to all first-line drugs. After 2 months of treatment, he remains sputum smear-positive. What is the most appropriate modification to his treatment regimen?
A. Continue the four-drug intensive phase for a third month, then switch to rifampicin and isoniazid for 7 months (Correct Answer)
B. Continue current four-drug regimen for total of 9 months without a continuation phase
C. Switch to second-line therapy with a fluoroquinolone, injectable agent, and three other drugs
D. Add a fluoroquinolone to the current four-drug regimen for the remainder of treatment
E. Continue with rifampicin and isoniazid only for 10 months
Explanation: ***Continue the four-drug intensive phase for a third month, then switch to rifampicin and isoniazid for 7 months***
- In patients with **extensive cavitary disease** and a high bacterial burden, the **intensive phase** is often extended if sputum remains positive at 2 months to ensure adequate clearance.
- Current guidelines for **cavitary TB** with delayed conversion recommend a total treatment duration of **9 to 10 months** to prevent relapse, specifically extending the continuation phase to 7 months.
*Continue current four-drug regimen for total of 9 months without a continuation phase*
- Maintaining the **full quadruple therapy** (including pyrazinamide and ethambutol) for the entire duration increases the risk of **toxicity** like hepatotoxicity and optic neuritis without proven extra benefit.
- Standard protocols always involve transitioning to a **continuation phase** with fewer drugs once the initial high-load bacterial population is reduced.
*Switch to second-line therapy with a fluoroquinolone, injectable agent, and three other drugs*
- This approach is reserved for **MDR-TB** (multi-drug resistant tuberculosis), whereas this patient’s isolate is **fully sensitive** to all first-line drugs.
- Switching to second-line agents is unnecessary and subjects the patient to significantly more **toxic side effects** and less effective medications.
*Add a fluoroquinolone to the current four-drug regimen for the remainder of treatment*
- Adding a single drug to a failing or slow-responding regimen violates the principle of TB therapy and can lead to **acquired drug resistance**.
- Fluoroquinolones are not indicated as a standalone addition for delayed sputum conversion in fully sensitive TB.
*Continue with rifampicin and isoniazid only for 10 months*
- Transitioning to **continuation phase** (RI only) when the patient is still smear-positive at 2 months is premature and risks treatment failure due to insufficient bactericidal activity.
- The patient's high bacterial burden (cavitary disease, 3+ AFB, delayed conversion) requires a more aggressive, extended intensive phase, not a reduced regimen.
Question 163: A 22-year-old university student presents to the emergency department with an 18-hour history of severe headache, photophobia, vomiting, and neck stiffness. Temperature is 39.2°C. There are no skin lesions. Lumbar puncture shows: opening pressure 32 cmH2O, glucose 1.9 mmol/L (serum 5.4 mmol/L), protein 2.4 g/L, white cells 2400/mm³ (95% neutrophils). Gram stain is negative. He is started on ceftriaxone and aciclovir. Blood and CSF cultures remain negative at 48 hours, and HSV PCR is negative. What is the most likely explanation for the negative microbiological results?
A. The patient has tuberculous meningitis with low bacterial load
B. Prior antibiotic administration before lumbar puncture has rendered cultures negative (Correct Answer)
C. The causative organism is Listeria monocytogenes which requires special culture media
D. The patient has viral meningitis and the neutrophilic predominance is atypical
E. The causative organism is Neisseria meningitidis which is fastidious and died during transport
Explanation: ***Prior antibiotic administration before lumbar puncture has rendered cultures negative***
- The patient's CSF profile (low **glucose**, high **protein**, and high **neutrophil** count) is classic for **bacterial meningitis**, but **prior antibiotics** can rapidly sterilize CSF, leading to negative cultures.
- Even a single dose of a broad-spectrum antibiotic like **ceftriaxone** can significantly reduce the yield of Gram stains and cultures within 2–4 hours of administration.
*The patient has tuberculous meningitis with low bacterial load*
- **Tuberculous meningitis** typically presents with a more **subacute** prodrome (weeks, not 18 hours) and usually shows **lymphocytic pleocytosis**.
- While CSF protein is high and glucose is low in TB, the extreme **neutrophilic predominance** (95%) seen here is highly unusual for Mycobacterium tuberculosis.
*The causative organism is Listeria monocytogenes which requires special culture media*
- **Listeria monocytogenes** is an uncommon cause of meningitis in a healthy 22-year-old student, typically affecting **neonates**, the **elderly**, or **immunocompromised** patients.
- Listeria grows well on standard blood agar and does not require highly specialized media; it would likely have grown if present and not inhibited by antibiotics.
*The patient has viral meningitis and the neutrophilic predominance is atypical*
- **Viral meningitis** is usually associated with a **lymphocytic predominance** and **normal glucose** levels; the very low glucose (1.9 mmol/L) and high pressure here strongly favor a bacterial etiology.
- While early viral meningitis can show neutrophils, the severity of the biochemical abnormalities (protein 2.4 g/L) is much more consistent with a **bacterial pathogen**.
*The causative organism is Neisseria meningitidis which is fastidious and died during transport*
- Although **Neisseria meningitidis** is fastidious, modern hospital laboratories use enriched media and transport protocols that make complete culture failure due to transport alone less likely than antibiotic interference.
- Given the clinical urgency and standard of care, the administration of antibiotics prior to the procedure remains the most statistically likely reason for sterile cultures in a **purulent CSF** sample.
Question 164: A 46-year-old man with smear-positive pulmonary tuberculosis has been receiving standard four-drug therapy for 8 weeks. His initial isolate showed susceptibility to all first-line drugs. He reports good adherence to treatment. Repeat sputum microscopy at 8 weeks remains smear-positive (2+ acid-fast bacilli). Repeat culture from week 6 shows growth of Mycobacterium tuberculosis. What is the most appropriate interpretation and management at this stage?
A. This represents treatment failure; the regimen should be changed to second-line drugs immediately
B. This is expected; continue current regimen and repeat sputum culture at 3 months (Correct Answer)
C. This suggests drug resistance; molecular testing for resistance mutations should be performed urgently and treatment modified
D. This indicates non-adherence; directly observed therapy should be instituted and treatment extended
E. This suggests laboratory contamination; treatment should be stopped and samples repeated
Explanation: ***This is expected; continue current regimen and repeat sputum culture at 3 months*** - In patients with **drug-susceptible TB** and high bacterial load (2+ smear), it is not uncommon for sputum to remain **culture-positive at 2 months**; conversion typically occurs by the end of the intensive phase.- **Treatment failure** is officially defined by positive cultures at **4 months** or later, so continuing the standard regimen while monitoring is the correct clinical pathway.*This represents treatment failure; the regimen should be changed to second-line drugs immediately* - **Treatment failure** cannot be diagnosed at only 8 weeks; diagnosing it prematurely leads to the unnecessary use of more toxic **second-line agents**.- Changing the regimen requires confirmed **drug susceptibility testing (DST)** results showing resistance or clinical/bacteriologic failure at a later stage.*This suggests drug resistance; molecular testing for resistance mutations should be performed urgently and treatment modified* - While resistance is a concern, the initial isolate confirmed **full susceptibility**, and the patient reports **good adherence**, making resistance less likely at this stage.- **Molecular testing** is not indicated as an emergency at 8 weeks because a persistent positive culture at this point is a known variation in patients with **extensive cavitary disease**.*This indicates non-adherence; directly observed therapy should be instituted and treatment extended* - The patient specifically reports **good adherence**, and persistent positivity at 2 months occurs in roughly 15-20% of patients even with perfect compliance.- While **Directly Observed Therapy (DOT)** is a standard of care, it is not an "interpretation" of the 2-month smear result, nor is automatic extension of treatment warranted yet.*This suggests laboratory contamination; treatment should be stopped and samples repeated* - A persistent **AFB smear (2+)** and a positive culture at week 6 are consistent findings in an active infection and are highly unlikely to be purely due to **contamination**.- **Stopping TB treatment** in a patient who was recently smear-positive is dangerous and could lead to rapid clinical deterioration and the development of **drug resistance**.
Question 165: A 63-year-old woman presents with confusion, fever, and right-sided focal seizures. She has a background of type 2 diabetes and chronic sinusitis. CT head shows a right temporal lobe lesion with surrounding oedema. Lumbar puncture shows: opening pressure 22 cmH2O, glucose 3.2 mmol/L (serum 7.8 mmol/L), protein 1.2 g/L, white cells 425/mm³ (65% neutrophils, 35% lymphocytes), red cells 85/mm³. Gram stain shows Gram-positive cocci in chains. What is the most appropriate initial antimicrobial regimen?
A. Intravenous ceftriaxone, vancomycin, and dexamethasone
B. Intravenous benzylpenicillin and metronidazole
C. Intravenous ceftriaxone and metronidazole (Correct Answer)
D. Intravenous ceftriaxone, metronidazole, and aciclovir
E. Intravenous meropenem and vancomycin
Explanation: ***Intravenous ceftriaxone and metronidazole***- The patient presents with clinical features highly suggestive of a **brain abscess** (confusion, fever, focal seizures, temporal lobe lesion) likely originating from **chronic sinusitis**.- The Gram stain showing **Gram-positive cocci in chains** points towards **Streptococcus species**. **Ceftriaxone** effectively covers these and other potential Gram-negative organisms, while **metronidazole** provides excellent coverage for **anaerobic bacteria**, which are common in sinogenic infections and brain abscesses.*Intravenous ceftriaxone, vancomycin, and dexamethasone*- **Vancomycin** is typically added for suspected **MRSA** or in post-neurosurgical infections. The Gram stain (Gram-positive cocci in chains) and community-acquired nature do not strongly suggest MRSA.- **Dexamethasone** is generally avoided in **brain abscesses** as it can impair **antibiotic penetration** into the abscess cavity, although it is used in bacterial meningitis for inflammation reduction.*Intravenous benzylpenicillin and metronidazole*- While **benzylpenicillin** covers Streptococcus species, it has a narrower spectrum compared to ceftriaxone and may not adequately cover potential **Gram-negative bacteria** associated with sinogenic infections.- **Ceftriaxone** is preferred due to its superior **central nervous system (CNS) penetration**, broader spectrum, and convenient once-daily dosing for prolonged treatment regimens required for brain abscesses.*Intravenous ceftriaxone, metronidazole, and aciclovir*- **Aciclovir** is the treatment for **Herpes Simplex Encephalitis (HSE)**. The presence of **Gram-positive cocci** on Gram stain definitively indicates a bacterial infection, making aciclovir inappropriate.- The **CSF findings** (low glucose, high protein, neutrophil predominance) are highly consistent with **bacterial infection**, not viral encephalitis.*Intravenous meropenem and vancomycin*- This broad-spectrum regimen is typically reserved for severe, **hospital-acquired infections**, post-operative cases, or infections involving **multidrug-resistant (MDR)** organisms.- For a **community-acquired brain abscess** secondary to sinusitis, ceftriaxone and metronidazole provide appropriate targeted coverage, minimizing the risk of developing **antibiotic resistance** associated with overly broad-spectrum antibiotics.
Question 166: A 35-year-old man from Afghanistan presents with a 10-week history of fever, night sweats, and back pain. MRI spine shows destruction of T10-T11 vertebrae with paraspinal abscess formation and spinal cord compression. He is neurologically intact. Three sputum samples are negative for acid-fast bacilli. What is the most appropriate immediate management approach?
A. Start four-drug anti-TB therapy and arrange urgent neurosurgical decompression within 24 hours (Correct Answer)
B. Perform CT-guided biopsy of the paraspinal abscess, await microbiology results before starting treatment
C. Start four-drug anti-TB therapy with high-dose corticosteroids and arrange elective surgical review
D. Start broad-spectrum antibiotics for bacterial spondylodiscitis and arrange MRI-guided biopsy
E. Perform urgent open biopsy and debridement with immediate four-drug anti-TB therapy
Explanation: ***Start four-drug anti-TB therapy and arrange urgent neurosurgical decompression within 24 hours***
- The presence of **spinal cord compression** on MRI, even without immediate neurological deficits, is a neurosurgical emergency requiring urgent decompression to prevent irreversible neurological damage.
- Given the patient's origin (Afghanistan), chronic systemic symptoms (fever, night sweats), and imaging findings (vertebral destruction, paraspinal abscess), **Pott's disease** is highly suspected, necessitating immediate empirical **four-drug anti-TB therapy**.
*Perform CT-guided biopsy of the paraspinal abscess, await microbiology results before starting treatment*
- Delaying treatment to wait for definitive **microbiology results** is contraindicated in the presence of active **spinal cord compression**, as rapid neurological deterioration can occur.
- While a **biopsy** is important for diagnosis, it should not precede urgent surgical decompression and empirical anti-TB treatment in this emergent scenario.
*Start four-drug anti-TB therapy with high-dose corticosteroids and arrange elective surgical review*
- An **elective surgical review** is inappropriate and dangerous for **spinal cord compression**; urgent intervention is required to prevent permanent neurological deficits like paraplegia.
- While **corticosteroids** might be used in specific TB manifestations, they do not alleviate mechanical cord compression and are not a substitute for urgent surgical decompression.
*Start broad-spectrum antibiotics for bacterial spondylodiscitis and arrange MRI-guided biopsy*
- The clinical picture (chronic symptoms, night sweats, paraspinal abscess, endemic origin) is highly suggestive of **tuberculosis** rather than typical pyogenic bacterial spondylodiscitis.
- Starting broad-spectrum antibiotics alone fails to address the critical and immediate threat of **spinal cord compression**, which requires mechanical relief.
*Perform urgent open biopsy and debridement with immediate four-drug anti-TB therapy*
- While open surgery and anti-TB therapy are essential, the most critical immediate component when **spinal cord compression** is present is **neurosurgical decompression** to relieve pressure on the spinal cord.
- The term
Question 167: A 4-year-old boy presents with a 12-hour history of fever, irritability, and drowsiness. On examination, he has a capillary refill time of 4 seconds, heart rate 155/min, blood pressure 85/50 mmHg, and a spreading non-blanching purpuric rash on his legs and trunk. He is managed in the emergency department with immediate antibiotics. His 18-month-old sibling attends the same nursery and has no symptoms. What is the most appropriate prophylaxis for the sibling?
A. Single dose of intramuscular ceftriaxone 125 mg
B. Oral ciprofloxacin 250 mg single dose
C. Oral rifampicin 10 mg/kg twice daily for 2 days (Correct Answer)
D. Oral azithromycin 10 mg/kg once daily for 3 days
E. No prophylaxis required as the sibling is asymptomatic
Explanation: ***Oral rifampicin 10 mg/kg twice daily for 2 days***
- The index case has **meningococcal septicaemia** (fever, shock, and purpuric rash), which requires urgent **chemoprophylaxis** for all close household contacts to eradicate nasopharyngeal carriage.
- **Rifampicin** is a standard first-line choice for children, typically administered for 2 days to prevent secondary cases in high-risk contacts.
*Single dose of intramuscular ceftriaxone 125 mg*
- **Ceftriaxone** is an effective alternative for prophylaxis and is useful for pregnant women or when oral medication is not tolerated.
- While it is a valid option, **Rifampicin** or **Ciprofloxacin** are more frequently used as initial oral choices for household contacts in clinical guidelines.
*Oral ciprofloxacin 250 mg single dose*
- **Ciprofloxacin** is a common choice for adult prophylaxis due to the convenience of a **single dose** and lack of interaction with oral contraceptives.
- However, the dose provided (250 mg) is incorrect for a child, and **Rifampicin** remains a traditional primary choice for pediatric populations in many protocols.
*Oral azithromycin 10 mg/kg once daily for 3 days*
- **Azithromycin** is not a standard recommended regimen for the chemoprophylaxis of **Neisseria meningitidis**.
- It is more commonly used for the prevention of secondary cases in **Pertussis** or used for generic bacterial respiratory infections.
*No prophylaxis required as the sibling is asymptomatic*
- Prophylaxis is mandatory for **household contacts** regardless of symptoms, as the risk of secondary disease is highest in the first 7 days.
- Asymptomatic carriers can transmit the bacteria to vulnerable individuals; therefore, treatment is aimed at **eradication of carriage** rather than treating active disease.
Question 168: A 28-year-old healthcare worker sustains a needlestick injury from a patient with confirmed multidrug-resistant tuberculosis (resistant to rifampicin and isoniazid). The healthcare worker has no symptoms and chest X-ray is normal. Mantoux test performed 48 hours ago shows 8 mm induration. She has no documented BCG vaccination. What is the most appropriate management for this exposed healthcare worker?
A. Observe clinically with chest X-ray every 3 months for 2 years
B. Start treatment with moxifloxacin and ethambutol for 6 months
C. Repeat Mantoux test in 6 weeks and treat if positive
D. Arrange interferon-gamma release assay (IGRA) and treat with levofloxacin and ethambutol if positive (Correct Answer)
E. Start treatment with pyrazinamide and ethambutol for 9 months
Explanation: ***Arrange interferon-gamma release assay (IGRA) and treat with levofloxacin and ethambutol if positive***
- An **IGRA** is recommended to confirm **Latent TB Infection (LTBI)**, as it is more specific than the Mantoux test and remains unaffected by BCG status.
- For **MDR-TB exposure**, the preventive regimen must be tailored to the source's sensitivity; a combination of a **fluoroquinolone** (like levofloxacin) and **ethambutol** is standard when isoniazid and rifampicin resistance is confirmed.
*Observe clinically with chest X-ray every 3 months for 2 years*
- **Active monitoring** alone is insufficient for a known high-risk **MDR-TB exposure** in a healthcare setting, especially with a positive Mantoux test.
- Current guidelines favor the treatment of **latent infection** to prevent progression to active, life-threatening multidrug-resistant disease, rather than just observation.
*Start treatment with moxifloxacin and ethambutol for 6 months*
- While this regimen is a valid choice for **MDR-LTBI**, it should only be initiated after **confirming infection** with an IGRA or a significant TST, rather than empirical treatment.
- Immediate treatment without further confirmation (like IGRA) or specialized **expert consultation** is not the standard first step for an 8mm TST in this high-risk context.
*Repeat Mantoux test in 6 weeks and treat if positive*
- The current induration of **8 mm** is already considered significant for a healthcare worker with recent **high-risk contact** to active TB, even without BCG.
- Delaying for a repeat test risks the window period for early **chemoprophylaxis** and is unnecessary when an IGRA can provide more immediate and reliable clarity.
*Start treatment with pyrazinamide and ethambutol for 9 months*
- **Pyrazinamide** is often poorly tolerated for long-term prophylaxis and has higher rates of **hepatotoxicity** compared to fluoroquinolones.
- Modern protocols for **MDR-LTBI** generally favor fluoroquinolone-based regimens due to better evidence of efficacy and a superior side-effect profile for prophylaxis.
Question 169: A 43-year-old man with HIV infection (CD4 count 95 cells/mm³, not on antiretroviral therapy) presents with a 3-week history of headache and fever. CT head shows multiple ring-enhancing lesions. Lumbar puncture shows: opening pressure 19 cmH2O, glucose 2.8 mmol/L (serum 5.2 mmol/L), protein 0.65 g/L, white cells 12/mm³ (lymphocytes). India ink stain is positive. Serum cryptococcal antigen titre is 1:2048. What is the most appropriate initial management strategy?
A. Liposomal amphotericin B and flucytosine for 2 weeks, then fluconazole consolidation (Correct Answer)
B. Oral fluconazole 800 mg daily for 10 weeks
C. Liposomal amphotericin B monotherapy for 6 weeks
D. Voriconazole and flucytosine for 2 weeks, then fluconazole consolidation
E. Liposomal amphotericin B and flucytosine for 4-6 weeks, then fluconazole consolidation
Explanation: ***Liposomal amphotericin B and flucytosine for 2 weeks, then fluconazole consolidation***
- The preferred induction regimen for **cryptococcal meningitis** in HIV patients is combination therapy with **liposomal amphotericin B** and **flucytosine** for at least 14 days.
- Combination therapy is superior to monotherapy as it ensures rapid sterilization of the **CSF** and reduces the risk of mortality and treatment failure.
*Oral fluconazole 800 mg daily for 10 weeks*
- **Fluconazole monotherapy** is considered suboptimal and is generally only used for induction in cases where amphotericin B and flucytosine are unavailable or contraindicated.
- It lacks the **fungicidal potency** required to treat high fungal burdens effectively, as evidenced by the high **antigen titre** in this patient.
*Liposomal amphotericin B monotherapy for 6 weeks*
- While amphotericin is fungicidal, using it as **monotherapy** is associated with worse clinical outcomes compared to the combination with flucytosine.
- Prolonged administration of amphotericin B without transitioning to oral agents unnecessarily increases the risk of **nephrotoxicity** and electrolyte imbalances.
*Voriconazole and flucytosine for 2 weeks, then fluconazole consolidation*
- **Voriconazole** is not the standard of care or first-line agent for the induction phase of cryptococcal meningitis.
- Guidelines prioritize **amphotericin-based regimens** due to better-established efficacy and survival data in this specific patient population.
*Liposomal amphotericin B and flucytosine for 4-6 weeks, then fluconazole consolidation*
- An induction period of **4-6 weeks** is typically discouraged in favor of a 2-week induction followed by a transition to oral agents to minimize hospital stay and drug toxicity.
- Longer induction is usually reserved only for patients who fail to show **clinical improvement** or fail to achieve **CSF sterilization** after the initial 2 weeks.
Question 170: A 31-year-old woman from Pakistan presents with a 6-week history of progressive headache, low-grade fever, and confusion. She is currently 20 weeks pregnant. MRI brain shows basal meningeal enhancement and hydrocephalus. CSF analysis shows: glucose 1.8 mmol/L (serum 4.5 mmol/L), protein 2.5 g/L, white cells 180/mm³ (80% lymphocytes). ZN stain is pending. Which combination represents the most appropriate initial treatment regimen for this patient?
A. Isoniazid, rifampicin, ethambutol, pyridoxine, and prednisolone
B. Isoniazid, rifampicin, pyrazinamide, ethambutol, and dexamethasone
C. Isoniazid, rifampicin, ethambutol, levofloxacin, pyridoxine, and dexamethasone (Correct Answer)
D. Rifampicin, ethambutol, levofloxacin, and prednisolone
E. Isoniazid, rifampicin, streptomycin, pyridoxine, and prednisolone
Explanation: ***Isoniazid, rifampicin, ethambutol, levofloxacin, pyridoxine, and dexamethasone***
- This patient presents with classic features of **tuberculous meningitis (TBM)**, indicated by basal enhancement, high CSF protein, low glucose, and **lymphocyte-predominant** pleocytosis.
- In **pregnancy**, pyrazinamide is often substituted with a **fluoroquinolone** like levofloxacin due to safety concerns; **dexamethasone** is added to reduce mortality from CNS inflammation, and **pyridoxine** prevents isoniazid-induced neuropathy.
*Isoniazid, rifampicin, ethambutol, pyridoxine, and prednisolone*
- While this contains several core components, it lacks a fourth active antimicrobial agent required for the **intensive phase** of TBM treatment.
- **Dexamethasone** is generally preferred over prednisolone in CNS tuberculosis due to its superior penetration and clinical evidence base for reducing **intracranial pressure**.
*Isoniazid, rifampicin, pyrazinamide, ethambutol, and dexamethasone*
- **Pyrazinamide** is traditionally avoided or used with caution in pregnancy in some regional guidelines (like the UK) due to limited human safety data despite WHO recommendations.
- Additionally, this option lacks **pyridoxine** (Vitamin B6), which is essential in pregnancy to prevent **peripheral neuropathy** caused by isoniazid.
*Rifampicin, ethambutol, levofloxacin, and prednisolone*
- This regimen is incorrect because it excludes **isoniazid**, which is a critical bactericidal agent for treating sensitive strains of **Mycobacterium tuberculosis**.
- The absence of **pyridoxine** and the use of the weaker steroid prednisolone makes this an suboptimal choice for managing severe TBM.
*Isoniazid, rifampicin, streptomycin, pyridoxine, and prednisolone*
- **Streptomycin** is strictly **contraindicated in pregnancy** because it is known to cause fetal **ototoxicity** (damage to the eighth cranial nerve).
- This regimen also lacks a fourth agent like ethambutol or a fluoroquinolone commonly used when traditional combinations are modified.
